Home » Markets

Image for Oppenheimer Weighs in on Exelixis, Inc.’s Q3 2022 Earnings (NASDAQ:EXEL)

Oppenheimer Weighs in on Exelixis, Inc.’s Q3 2022 Earnings (NASDAQ:EXEL)

Exelixis, Inc. (NASDAQ:EXEL – Get Rating) – Equities research analysts at Oppenheimer lifted their Q3 2022 EPS estimates for shares of Exelixis in a research report issued to clients and investors on Tuesday, August... More of this article »
Image for Panbela Therapeutics (PBLA) to Release Quarterly Earnings on Monday

Panbela Therapeutics (PBLA) to Release Quarterly Earnings on Monday

Panbela Therapeutics (NASDAQ:PBLA – Get Rating) will release its earnings data after the market closes on Monday, August 15th. Analysts expect Panbela Therapeutics to post earnings of ($0.22) per share for the quarter. Parties... More of this article »
Image for Q3 2022 EPS Estimates for Minerva Neurosciences, Inc. (NASDAQ:NERV) Boosted by William Blair

Q3 2022 EPS Estimates for Minerva Neurosciences, Inc. (NASDAQ:NERV) Boosted by William Blair

Minerva Neurosciences, Inc. (NASDAQ:NERV – Get Rating) – Research analysts at William Blair lifted their Q3 2022 earnings per share estimates for shares of Minerva Neurosciences in a report issued on Tuesday, August... More of this article »
Image for CF Industries (NYSE:CF) Lifted to “Overweight” at Barclays

CF Industries (NYSE:CF) Lifted to “Overweight” at Barclays

Barclays upgraded shares of CF Industries (NYSE:CF – Get Rating) from an equal weight rating to an overweight rating in a research report sent to investors on Wednesday, Marketbeat reports. The brokerage currently has $120.00... More of this article »
Image for SVB Leerink Raises AdaptHealth (NASDAQ:AHCO) Price Target to $29.00

SVB Leerink Raises AdaptHealth (NASDAQ:AHCO) Price Target to $29.00

AdaptHealth (NASDAQ:AHCO – Get Rating) had its price objective hoisted by SVB Leerink from $24.00 to $29.00 in a report released on Wednesday morning, The Fly reports. The brokerage currently has an outperform rating on the stock.... More of this article »